Scarica l'app Stockscreener
12.55
8.48%
-1.185
Dopo l'orario di chiusura:
12.55
-0.005
-0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CC Giù?
Forum
Previsione
Storia dei dividendi
Chemours Company Borsa (CC) Ultime notizie
Best data tools to analyze The Chemours Company stockPortfolio Performance Report & Reliable Intraday Trade Plans - newser.com
The Chemours Company stock prediction for this weekWeekly Trade Analysis & High Accuracy Investment Entry Signals - newser.com
Published on: 2025-10-10 09:12:34 - newser.com
What data driven models say about The Chemours Company’s future2025 Analyst Calls & Weekly Watchlist of Top Performers - newser.com
Trend analysis for The Chemours Company this weekQuarterly Trade Report & High Win Rate Trade Tips - newser.com
Will The Chemours Company stock recover after recent dropQuarterly Portfolio Report & Precise Entry and Exit Recommendations - newser.com
undefined - CSRwire
What analysts say about The Chemours Company 2CU stockEarnings Growth Projections & Minimal Capital Trading Tips - earlytimes.in
Using fundamentals and technicals on The Chemours CompanyJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
Is The Chemours Company (2CU) stock prepared for digital transitionJuly 2025 Fed Impact & AI Powered Market Entry Strategies - newser.com
Pigments Market Size Worth US$ 39.36 billion by 2031 | Chemours, - openPR.com
Chemours' Trusted Chemistry in Action: Improving Data Center Impact Through Liquid Cooling - ACCESS Newswire
Chemours Co. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Is Chemours Set for a Rebound After Recent Legal Settlement Shakes Up the Stock? - simplywall.st
Luminus Trims Its Hefty Chemours Position - AOL.com
UBS Maintains Chemours (CC) Buy Recommendation - Nasdaq
Chemours’ Approach to Responsible Manufacturing and Mining - CSRwire
UBS Raises Chemours (CC) Price Target to $21.00 and Reaffirms Bu - GuruFocus
UBS Adjusts Price Target on Chemours to $21 From $17, Maintains Buy Rating - MarketScreener
GAMMA Investing LLC Has $36,000 Position in The Chemours Company $CC - Defense World
Chemours’ Role In Shaping the Russell 1000 Index Performance - kalkinemedia.com
The Chemours Company’s volatility index tracking explainedChart Signals & AI Optimized Trading Strategy Guides - newser.com
Applying Elliott Wave Theory to The Chemours Company2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Can The Chemours Company (2CU) stock resist broad market declines2025 Short Interest & Verified Technical Signals - newser.com
3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending - MarketBeat
Head to Head Comparison: Chemours (NYSE:CC) vs. Lsb Industries (NYSE:LXU) - Defense World
Chemours (CC) Price Target Lifted by Mizuho Amid Higher Market Multiples - MSN
United States Titanium Market: Corrosion Resistance & Chemical - openPR.com
Chemours' Approach to Responsible Manufacturing and Mining - ReportAlert
Chemours Getting Closer To Key Technical Measure - Investor's Business Daily
Local organizations push through water quality setbacks as threat of more PFAS looms - Goldsboro News-Argus
Biz Groups Say They Can Be Amici In 4th Circ. Pollution Suit - Law360
Chemours Co. Experiences Revision in Stock Evaluation Amid Market Dynamics and Volatility - Markets Mojo
Jefferies Reaffirms Their Hold Rating on Chemours Company (CC) - The Globe and Mail
Is The Chemours Company a good long term investmentTrade Execution Strategies & Identify Winning Stocks - earlytimes.in
Chemours, DuPont Lose, for Now, Bid to Exit PFAS Damage Case - Bloomberg Law News
Bourgeon Capital Management LLC Trims Stock Position in The Chemours Company $CC - MarketBeat
Jefferies raises Chemours stock price target to $16 from $11, maintains Hold rating - Investing.com UK
The Chemours Company (NYSE:CC) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
8 Best Specialty Chemicals Stocks to Invest In - Insider Monkey
Chemours (CC): How Analyst Optimism and TiO2 Market Shifts Are Shaping the Company's Valuation Outlook - simplywall.st
What analysts say about The Chemours Company stockHealthcare Stock Analysis & Superior Portfolio Investment - Early Times
6.64%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):